- ►nih.gov J Costa, M Borges, C David, AV Carneiro - British Medical Journal, 2006 - bmj.com The prevalence of diabetes mellitus is increasing. Up to 218 mil- lion people
are likely to have the disease by 2010.1 The current understanding is that type
2 diabetes mellitus is a metabolic dis- order, defined by hyperglycaemia, ... Cited by 146 - Related articles - BL Direct - All 9 versions
RA Hayward, TP Hofer, S Vijan - Annals of internal medicine, 2006 - Am Coll Physicians Recent national recommendations have proposed that physicians should titrate
lipid therapy to achieve low-density lipoprotein (LDL) cholesterol levels less
than 1.81 mmol/L (<70 mg/dL) for patients at very high cardiovascular risk ... Cited by 99 - Related articles - BL Direct - All 6 versions
V Snow, MD Aronson, ER Hornbake, C Mottur- … - Annals of internal medicine, 2004 - Am Coll Physicians In an effort to provide internists and other primary care physicians with
effective management strategies for diabetes care, the Clinical Efficacy
Assessment Subcommittee (CEAS) of the American College of Physicians (ACP) ... Cited by 96 - Related articles - All 7 versions
- ►diabetesjournals.org SL Krein, M Heisler, JD Piette, F Makki, EA … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This is a cross-sectional study of 993 patients
with diabetes receiving care through the Department of Veterans Affairs (VA).
Data on chronic pain, defined as pain present most of the time for 6 months ... Cited by 53 - Related articles - All 6 versions
- ►nih.gov JYF Wu, W Leung, S Chang, B Lee, B Zee, … - British Medical Journal, 2006 - bmj.com Main outcome measures Primary outcome was all cause mortality in randomised
patients. Associations between compliance and mortality in the entire cohort of
1011 patients were also examined. Patients were defined as compliant with a ... Cited by 55 - Related articles - BL Direct - All 9 versions
E Bruckert, M Baccara-Dinet, F McCoy, J … - Current Medical Research and Opinion®, 2005 - informahealthcare.com Objective: Low HDL-cholesterol is a strong independent cardiovascular risk
factor recognized as a therapeutic target in recent guidelines. The Pan-European
Survey on HDL-cholesterol collected data on plasma lipid profiles from 8545 ... Cited by 49 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] ED Beishuizen, MA van de Ree, JW Jukema, … - Diabetes Care, 2005 - Am Diabetes Assoc The National Cholesterol Education Program (NCEP) guidelines recom- mend use of
statin-fibrate combina- tions to treat combined dyslipidemia. Myopathy and
rhabdomyolysis are re- ported side effects, especially with gemfi- ... Cited by 43 - Related articles - BL Direct - All 11 versions
W Bestermann, MC Houston, J Basile, B Egan … - The American journal of the medical sciences, 2005 - journals.lww.com From the Consortium for Southeastern Hypertension Control, and from the Low
Country Medical Group, Beaufort, South Carolina (wb), Vanderbilt University
School of Medicine and St. Thomas Hospital, Nashville, Tennessee (mch, ... Cited by 41 - Related articles - All 5 versions
SH Kim, SJ Lee, ES Kang, S Kang, KY Hur, … - Metabolism, 2006 - Elsevier The aim of this study was to examine the effects of a 6-month intensive
lifestyle modification intervention on metabolic parameters and carotid
intima-media thickness (IMT) in patients with type 2 diabetes mellitus. ... Cited by 38 - Related articles - All 15 versions
ED Beishuizen, JT Tamsma, JW Jukema, MA … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Cardiovascular disease (CVD) is the most important cause of
mortality in patients with type 2 diabetes and is preceded by endothelial
dysfunction. Flow-mediated dilation (FMD) is a noninvasive technique for ... Cited by 26 - Related articles - BL Direct - All 5 versions
